Sign in
TerminatedNo phase

Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM)

Key facts

Who runs it
Institut de cancérologie Strasbourg Europe
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
8 people enrolled
Started
7 May 2021
Ended
17 Jun 2025
Type of study
Interventional
Treatments tested
  • Optimisation of dental implant sites protection from irradiation
Record updated
5 January 2026
Why it stopped
organisationnal reason

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Patients must be ≥ 18 years old
  • Performance Status 0 to 2
  • Histologically-confirmed diagnosis of : infiltrating squamous cell carcinoma of the oral cavity or oropharynx
  • Indication for an exclusive radiotherapy or post-surgery radiotherapy, with or without chemotherapy
  • Indication for a radiotherapy of lymph node areas
  • Partial or complete toothlessness requiring rehabilitation
  • Signed informed consent from the patient

Who cannot take part

  • History of head and neck radiotherapy
  • Partial mandibulectomy
  • Retarded wound healing or trismus impairing radiological guide preparation
  • Patient refusing the study
  • Pregnant women

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a monocentric, non-randomized, prospective, in silico feasibility study conducted by Strasbourg Europe Cancerology Institute. The purpose of this study is to evaluate the optimisation of potential dental implant sites protection, without degrading tumor volume coverage, through designation of potential dental implant sites before volume delineation and dosimetry calculations in patients with oropharyngeal or oral cavity squamous cell carcinoma treated by radiotherapy.

The group in the trial

  • Patients with oral cavity or oropharyngeal squamous cell carcinomaOther group

    Treatment: Optimisation of dental implant sites protection from irradiation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
5 January 2026